Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women

Mickael Hiligsmann, Annelies Boonen, Carmen D. Dirksen, Wafa Ben Sedrine, Jean-Yves Reginster

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)19-28
JournalExpert Review of Pharmacoeconomics & Outcomes Research
Volume13
Issue number1
DOIs
Publication statusPublished - Feb 2013

Keywords

  • cost-effectiveness
  • denosumab
  • osteoporosis

Cite this